Cost-effectiveness of prophylactic cervical cancer vaccination in Greece

Journal Title: Αρχεία Ελληνικής Ιατρικής - Year 2010, Vol 27, Issue 1

Abstract

OBJECTIVES To estimate the cost-effectiveness (from the health care payer's perspective) of prophylactic cervical cancer screening and vaccination of Greek girls at the age of 12 years, compared with screening alone. METHOD A Markov model was used to assess costs and consequences in the longer term. Input data for the model were obtained from various providers in the Greek private health sector, literature reviews, and expert opinion. Univariate sensitivity analysis was conducted to test the robustness of the results. RESULTS Using a discount rate of 3% on both costs and outcomes, the analysis resulted in an ICER of €19,012 per QALY. Sensitivity analysis on key variables resulted in relatively small effects on the ICER, which in all cases but one remained below the European accepted value of €50,000 per QALY. The analysis also provided further outcome measures which cannot be ignored by those responsible for deciding on a general vaccination recommendation: 412 cancer cases and 95 deaths from cervical cancer could be prevented by vaccinating 12 year-old girls in Greece. CONCLUSIONS When combined with current patterns of screening, prophylactic cervical cancer vaccination in Greek girls at the age of 12 years is very cost-effective. The results of this study (which to our knowledge is the first ever made in Greece) should not be ignored by decision-makers, and national health policy for the prevention of cervical cancer should include a targeted vaccination scheme.

Authors and Affiliations

D. ROVITHIS, L. LIAROPOULOS

Keywords

Related Articles

The impact of factor V Leiden and G20210A prothrombin mutations on carotid stenosis in type 2 diabetes mellitus

OBJECTIVE Diabetes mellitus (DM) is an independent risk factor for arterial thrombosis. Patients with DM have severe carotid stenosis and increased intima-media thickness (IMT). Factor V (Leiden) and factor II (G20210A p...

Enhancement by arachidonic acid of the activity of antibiotics<br /> on experimental by multidrug-resistant Pseudomonas aeruginosa sepsis

OBJECTIVE Treatment of experimental multidrug-resistant Pseudomonas aeruginosa sepsis with intravenous co-administration of arachidonic acid (AA), ceftazidime and amikacin. METHOD The study was conducted using 21 rabb...

Nutritional treatment of obesity in adults. What is certain and what uncertain

The composition of diets against obesity varies greatly. Individualization of the diet is a very important factor for long-term compliance and for obtaining a satisfactory result. Only diets which respect the principles...

Current treatment of descending thoracic aortic aneurysms

Vascular diseases occur very often in Greece, as in all countries of the western world, and their incidence is expected to increase as life expectancy increases. The incidence of thoracic aortic aneurysms is calculated a...

Download PDF file
  • EP ID EP102411
  • DOI -
  • Views 68
  • Downloads 0

How To Cite

D. ROVITHIS, L. LIAROPOULOS (2010). Cost-effectiveness of prophylactic cervical cancer vaccination in Greece . Αρχεία Ελληνικής Ιατρικής, 27(1), 88-94. https://europub.co.uk/articles/-A-102411